Literature DB >> 10863008

Amino acid sequence of piratoxin-II, a myotoxic lys49 phospholipase A(2) homologue from Bothrops pirajai venom.

M H Toyama1, A M Soares, L Wen-Hwa, I Polikarpov, J R Giglio, S Marangoni.   

Abstract

The complete amino acid sequence of the 121 amino acid residues of piratoxin II, a phospholipase A(2) like myotoxin from Bothrops pirajai venom, is reported. PrTX-II is a basic protein with a molecular mass of 13740 Da, a calculated pI of 9.03, but an experimental pI of 8.4 +/- 0.2, showing sequence similarity with other bothropic (90-99%) or non-bothropic ( approximately 80%) Lys49 PLA(2)-like myotoxins. This similarity falls to approximately 70% when this sequence is aligned with that of Asp49 PLA(2). Due to the substitution of Asp49 by Lys49 and alterations in the calcium binding loop structure, as the replacement of Gly32 by Leu32, piratoxin-II shows no PLA(2) activity when assayed on egg yolk. Piratoxin-II showed the same primary structure as piratoxin-I, except that it has Lys116 for Leu116. Despite this slightly higher basicity at the C-terminal region, piratoxin-II was shown to be less myotoxic than piratoxin-I. The change Leu --> Lys induced an alteration of the molecule surface shape and probably of the environment charge high enough to slightly decrease the myotoxic activity. When aligned with B. jararacussu bothropstoxin-I and with B. asper Basp-II, piratoxin-II revealed a single (position 132) and a quintuple (positions 17, 90, 111, 120 and 132) amino acid substitution, respectively, suggesting a common evolutionary origin for these three myotoxins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863008     DOI: 10.1016/s0300-9084(00)00202-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

1.  Determination of the amino acid sequence of a new phospholipase A(2) (MIDCA1) isolated from Micrurus dumerilii carinicauda venom.

Authors:  Cháriston A Dal Belo; Marcos H Toyama; Daniela de O Toyama; Sergio Marangoni; F B Moreno; Benildo S Cavada; Marcos D Fontana; S Hyslop; E M Carneiro; Antonio C Boschero
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

2.  Determination of primary structure of two isoforms 6-1 and 6-2 PLA2 D49 from Bothrops jararacussu snake venom and neurotoxic characterization using in vitro neuromuscular preparation.

Authors:  L A Ponce-Soto; V L Bonfim; L Rodrigues-Simioni; J C Novello; S Marangoni
Journal:  Protein J       Date:  2006-02       Impact factor: 2.371

3.  Biochemical, pharmacological and structural characterization of a new PLA2 from Crotalus durissus terrificus (South American rattlesnake) venom.

Authors:  Saraguaci Hernandez-Oliveira; Marcos Hikari Toyama; Daniela Oliveira Toyama; Sergio Marangoni; Stephen Hyslop; Léa Rodrigues-Simioni
Journal:  Protein J       Date:  2005-05       Impact factor: 2.371

4.  Effects of low molecular weight sulfated galactan fragments from Botryocladia occidentalis on the pharmacological and enzymatic activity of sPLA2 from Crotalus durissus cascavella.

Authors:  M H Toyama; D O Toyama; V M Torres; G C Pontes; W R L Farias; F R Melo; S C B Oliveira; F H R Fagundes; E B S Diz Filho; B S Cavada
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

5.  Structural characterization and neuromuscular activity of a new Lys49 phospholipase A(2) homologous (Bp-12) isolated from Bothrops pauloensis snake venom.

Authors:  Priscila Randazzo-Moura; L A Ponce-Soto; Léa Rodrigues-Simioni; Sérgio Marangoni
Journal:  Protein J       Date:  2008-09       Impact factor: 2.371

6.  Modulation of the pharmacological effects of enzymatically-active PLA2 by BTL-2, an isolectin isolated from the Bryothamnion triquetrum red alga.

Authors:  Simone Cb Oliveira; Fabiana V Fonseca; Edson Antunes; Enilton A Camargo; Rafael P Morganti; Ricardo Aparício; Daniela O Toyama; Luís Os Beriam; Eudismar V Nunes; Benildo S Cavada; Celso S Nagano; Alexandre H Sampaio; Kyria S Nascimento; Marcos H Toyama
Journal:  BMC Biochem       Date:  2008-06-06       Impact factor: 4.059

Review 7.  Pharmacokinetics of Snake Venom.

Authors:  Suchaya Sanhajariya; Stephen B Duffull; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2018-02-07       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.